A trial to assess vildagliptin on pregnancy outcomes in patients with type 2 diabetes mellitus
Phase of Trial: Phase IV
Latest Information Update: 11 Nov 2014
At a glance
- Drugs Vildagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors Novartis Pharma A.G.
- 11 Nov 2014 New trial record
- 17 Sep 2014 Results presented at the 50th Annual Meeting of the European Association for the Study of Diabetes.